U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H16N2O5S
Molecular Weight 300.331
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4-CARBOXY TOLBUTAMIDE

SMILES

CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C(O)=O

InChI

InChIKey=GCMVATDSSHTCOS-UHFFFAOYSA-N
InChI=1S/C12H16N2O5S/c1-2-3-8-13-12(17)14-20(18,19)10-6-4-9(5-7-10)11(15)16/h4-7H,2-3,8H2,1H3,(H,15,16)(H2,13,14,17)

HIDE SMILES / InChI

Molecular Formula C12H16N2O5S
Molecular Weight 300.331
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Comparative metabolism of tolbutamide by isolated hepatocytes from rat, rabbit, dog, and squirrel monkey.
1984 Mar-Apr
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:15:14 GMT 2023
Edited
by admin
on Sat Dec 16 09:15:14 GMT 2023
Record UNII
JGR4FM80VY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
4-CARBOXY TOLBUTAMIDE
Common Name English
TOLBUTAMIDE CARBOXYLIC ACID
Common Name English
CARBOXYTOLBUTAMIDE
Common Name English
1-BUTYL-3-(P-CARBOXYPHENYL)SULFONYLUREA
Systematic Name English
BENZOIC ACID, 4-((((BUTYLAMINO)CARBONYL)AMINO)SULFONYL)-
Systematic Name English
CARBOXYCARBUTAMIDE
Common Name English
Code System Code Type Description
FDA UNII
JGR4FM80VY
Created by admin on Sat Dec 16 09:15:14 GMT 2023 , Edited by admin on Sat Dec 16 09:15:14 GMT 2023
PRIMARY
CAS
2224-10-4
Created by admin on Sat Dec 16 09:15:14 GMT 2023 , Edited by admin on Sat Dec 16 09:15:14 GMT 2023
PRIMARY
EPA CompTox
DTXSID10176780
Created by admin on Sat Dec 16 09:15:14 GMT 2023 , Edited by admin on Sat Dec 16 09:15:14 GMT 2023
PRIMARY
PUBCHEM
159651
Created by admin on Sat Dec 16 09:15:14 GMT 2023 , Edited by admin on Sat Dec 16 09:15:14 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE INACTIVE